SOUTH SAN FRANCISCO, CA -- (MARKET WIRE) -- April 18, 2007 -- Cytokinetics, Incorporated (NASDAQ: CYTK) announced the presentation of non-clinical data at the 2007 Annual Meeting of the American Association for Cancer Research (AACR) held in Los Angeles, CA from April 14-18, 2007. The presentations covered data evaluating ispinesib, a novel inhibitor of kinesin spindle protein (KSP), in models of multiple myeloma, data evaluating GSK-923295, a novel inhibitor of centrosome associated protein E (CENP-E) in both biochemical assays and in xenograft models and data from a separate, novel Cytokinetics cell-based drug discovery program.
